Top

Cardiovascular Drugs and Therapy

Published in:

01-08-2007

Pretreatment with Sarafotoxin 6c Prior to Coronary Occlusion Protects Against Infarction and Arrhythmias via Cardiomyocyte Mitochondrial K_ATP Channel Activation in the Intact Rabbit Heart During Ischemia/Reperfusion

Authors: Biswadeep Das, Chayna Sarkar, P Ravi Shankar

Published in: Cardiovascular Drugs and Therapy | Issue 4/2007

Abstract

Background

Endothelial ET_B receptor activation by exogenously administered sarafotoxin 6c(a snake venom peptide with a sequence homology to ET-1 prior to ischemia activates release of nitric oxide(NO) and previous studies have shown that NO facilitates mitochondrial K_ATP activation in cardiac cells and cardioprotection.

Objectives and methods

The aim of this investigation was to test whether the administration of sarafotoxin 6c(a selective ET_B receptor agonist) has cardioprotective and antiarrhythmic effects against ischemia and reperfusion injury in a well-standardized model of reperfusion arrhythmias in anesthetized adult male rabbits (n = 53) subjected to 30 min occlusion of the left coronary artery followed by 120 min of reperfusion.

Results

Pretreatment with sarafotoxin 6c (0.24 nmol/kg, i.v.) prior to the period of coronary occlusion offers significant infarct size reduction (19.1 ± 2.0% versus 39.7 ± 3.7% in the saline control group; P < 0.01) and antiarrhythmic effects. Sarafotoxin 6c treatment significantly attenuated the incidence of life-threatening arrhythmias like sustained VT (13 versus 100% in the saline control group; P < 0.005) and other arrhythmias (25 versus 100% in the saline control group; P < 0.005), and increased the number of surviving animals without arrhythmias. Pretreatment with 5-HD but not HMR 1883 abolished the beneficial effects of sarafotoxin 6c on reperfusion induced arrhythmias and cardioprotection suggesting that benefits have been achieved via the selective activation of cardiomyocyte mitochondrial K_ATP channels. Sarafotoxin 6c evoked NO release and selective activation of mitoK_ATP channels in cardiomyocytes contributes to cardioprotection and antiarrhythmic activity during ischemia-reperfusion in the anesthetized rabbit.

Conclusions

We conclude that the selective activation of ET_B receptors by sarafotoxin 6c prior to coronary occlusion contributes to cardioprotective and antiarrhythmic properties.

Wainwright CL, McCabe C, Kane KA. Endothelin and the ischemic heart. Curr Vasc Pharmacol 2005;3:333–41.PubMedCrossRef

Russell FD, Molenaar P. The human heart endothelin system: ET-1 synthesis, storage, release and effect. Trends Pharmacol Sci 2000;21:353–9.PubMedCrossRef

Allen BG, Phuong LL, Farhat H, Chevalier D. Both endothelin-A and endothelin-B receptors are present on adult rat cardiac ventricular myocytes. Can J Physiol Pharmacol 2003;81:95–104.PubMedCrossRef

D’Orleans-Juste PD, Labonte J, Bkaily G, Choufani S, Plante M, Honore JC. Function of the endothelin B receptor in cardiovascular physiology and pathophysiology. Pharmacol Ther 2002;95:221–38.PubMedCrossRef

Bugge E, Ytrehus K. Endothelin-1 can reduce infarct size through protein kinase C and K_ATP channels in the isolated rat heart. Cardiovasc Res 1996;32:920–9.PubMedCrossRef

Gourine AV, Molosh AI, Poputnikov D, Bulhak A, Sjoquist PO, Pernow J. Endothelin-1 exerts a preconditioning-like cardioprotective effect against ischemia/reperfusion injury via the ET_A receptor and the mitochondrial K_ATP channel in the rat in vivo. Br J Pharmacol 2005;144:331–7.CrossRef

Sharif I, Kane KA, Wainwright CL. Endothelin and ischemic arrhythmias-antiarrhythmic or arrhythmogenic? Cardiovasc Res 1998;39:625–32.PubMedCrossRef

Gross GJ, Auchampach JA. Blockade of ATP sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223–33.PubMed

Crockett TR, Gray GA, Kane KA, Wainwright CL. Sarafotoxin 6c (S6c) reduces infarct size and preserves mRNA for the ETB receptor in the ischemic/reperfused myocardium of anesthetized rats. J Cardiovasc Pharmacol 2004;44:148–54.PubMedCrossRef

10.

DeNucci G, Gryglewski RJ, Warner TD, Vane JR. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc Natl Acad Sci USA 1988;85:2334–8.CrossRef

11.

Lodge NJ, Zhang R, Halaka NN, Moreland S. Functional role of endothelin ETA and ETB receptors in venous and arterial smooth muscle. Eur J Pharmacol 1995;287:279–85.PubMedCrossRef

12.

Sasaki N, Sato T, Ohler A, O’Rourke B, Marban E. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 2000;101:439–45.PubMed

13.

Anonymous. Guidelines for care and use of animals in scientific research. Revised ed. Indian National Science Academy, New Delhi 2000.

14.

Bolli R, Patel BS. Factors that determine the occurrence of reperfusion arrhythmias. Am Heart J 1988;115:20–9.PubMedCrossRef

15.

Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987;21:737–46.PubMed

16.

Das B, Sarkar C. Is the sarcolemmal or mitochondrial K_ATP channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model? Life Sci 2005;77:1226–48.PubMedCrossRef

17.

Walker MJA, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia, infarction and reperfusion. Cardiovasc Res 1988;22:447–55.PubMed

18.

Kartha VNR, Krishnamurthy S. Factors affecting in vitro lipid peroxidation in rat brain homogenate. Indian J Physiol Pharmacol 1978;22:44–52.PubMed

19.

Dillard CJ, Kunert KJ, Tappel AL. Effects of vitamin E, ascorbic acid and mannitol on alloxan induced lipid peroxidation in rats. Arch Biochem Biophys 1982;216:204–10.PubMedCrossRef

20.

Beutler E, Daron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:883–7.

21.

Beauchamp C, Fridovich I. Superoxide dismutase: an improved assay applicable to acrylamide gel. Ann Biochem 1971;44:276–87.CrossRef

22.

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951;193:256–75.

23.

Bergmeyer HU (Ed): Methods of enzymatic analysis, Vols. 6–8, VCH Verlagsgesellschaft, Basel (1984–1985).

24.

Atkinson DE, Walton GM. Adenosine triphosphate conversion in metabolic regulation. Rat liver citrate cleavage enzyme. J Biol Chem 1967;242:3239–41.PubMed

25.

Crockett TR, Sharif I, Kane KA, Wainwright CL. Sarafotoxin 6c protects against ischemia-induced cardiac arrhythmias in vivo and in vitro in the rat. J Cardiovasc Pharmacol 2000;36:S297–9.PubMedCrossRef

26.

27.

Sargent CA, Liu EC, Chao CC, Monshizadegan H, Webb ML, Grover GJ. Role of endothelin receptor subtype B (ET-B) in myocardial ischemia. Life Sci 1994;55:1833–44.PubMedCrossRef

28.

Shinbo A, Iijima T. Potentiation by nitric oxide of the ATP-sensitive K⁺ current induced by K⁺ channel openers in guinea-pig ventricular cells. Br J Pharmacol 1997;120:1568-74.PubMedCrossRef

29.

Mery PF, Pavoine C, Belhassen L, Pecker F, Fischmeister R. Nitric oxide regulates cardiac Ca²⁺ current: involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 1993;268:26286–95.PubMed

30.

Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Inoue M, et al. Increased release of NO during ischemia decreases myocardial contractility and improves metabolic dysfunction. Circulation 1996;93:356–64.PubMed

31.

Depre C, Vanoverschelde JL, Goudemant JF, Mottet I, Hue L. Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation 1995;92:1911–8.PubMed

32.

Crockett TR, McBride M, Ness KF, Kane KA, Wainwright CL. The effect of S6c on platelet aggregation and leukocyte free radical generation in rat blood in vitro and ex vivo.Br J Pharmacol 2000;131:162P.

33.

Zhang DX, Chen YF, Campbell WB, Zou AP, Gross GJ, Li PL. Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels. Circ Res 2001;89:1177–83.PubMed

34.

Lefer DJ, Scalia R, Campbell B, Nossuli T, Hayward R, Salamon M, et al. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest 1997;99:684–91.PubMedCrossRef

35.

Altug S, Demiryurek AT, Cakici I, Kanzik I. The beneficial effects of peroxynitrite on ischemia reperfusion arrhythmias in isolated rat hearts. Eur J Pharmacol 1999;384:157–62.PubMedCrossRef

36.

Saito T, Itoh H, Chun T, Iqaki T, Mori Y, Yamashita J, et al.,. Oxidative stress suppresses the endothelial secretion of endothelin. J Cardiovasc Pharmacol 1998;31:S345–7.PubMedCrossRef

37.

Kristiansen SB, Nielsen-Kudsk JE, Botker HE, Nielsen TT. Effects of K_ATP channel modulation on myocardial glycogen content, lactate, and amino acids in nonischemic and ischemic rat hearts. J Cardiovasc Pharmacol 2005;45:456–61.PubMedCrossRef

38.

Kawahara K, Hachiro T, Yokokawa T, Nakajima T, Yamauchi Y, Nakayama Y. Ischemia/reperfusion-induced death of cardiac myocytes: possible involvement of nitric oxide in the coordination of ATP supply and demand during ischemia. J Mol Cell Cardiol 2006;40:35–46.PubMedCrossRef

Title: Pretreatment with Sarafotoxin 6c Prior to Coronary Occlusion Protects Against Infarction and Arrhythmias via Cardiomyocyte Mitochondrial KATP Channel Activation in the Intact Rabbit Heart During Ischemia/Reperfusion
Authors: Biswadeep Das
Chayna Sarkar
P Ravi Shankar
Publication date: 01-08-2007
Publisher: Springer US
Published in: Cardiovascular Drugs and Therapy / Issue 4/2007
Print ISSN: 0920-3206
Electronic ISSN: 1573-7241
DOI: https://doi.org/10.1007/s10557-007-6031-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pretreatment with Sarafotoxin 6c Prior to Coronary Occlusion Protects Against Infarction and Arrhythmias via Cardiomyocyte Mitochondrial K_ATP Channel Activation in the Intact Rabbit Heart During Ischemia/Reperfusion

Abstract

Background

Objectives and methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objectives and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2007

Effects of Levosimendan on Quality of Life and Emotional Stress in Advanced Heart Failure Patients

Necrostatin: A Potentially Novel Cardioprotective Agent?

Myocardial Ischaemia-reperfusion Injury is Attenuated by Intact Glucagon Like Peptide-1 (GLP-1) in the In Vitro Rat Heart and may Involve the p70s6K Pathway

The Effect of Hydrogen Peroxide in Human Internal Thoracic Arteries: Role of Potassium Channels, Nitric Oxide and Cyclooxygenase Products

Potential Effects of Angiotensin II Receptor Blockers on Glucose Tolerance and Adiponectin Levels in Hypertensive Patients

Transforming Growth Factor and Nuclear Factor Kappa B Mediated Prophylactic Cardioprotection by Total Flavonoids of Fructus Chorspondiatis in Myocardial Ischemia